References

Filters: Author is Zeuzem, Stefan  [Clear All Filters]
Z
Zeuzem S, Feld J, Wang S. ENDURANCE-1: Efficacy and Safety of 8- versus 12-week Treatment with ABT-493/ABT-530 in patients with Chronic HCV Genotype 1 Infection [Abstract 253]. In: 67th Annual Meeting of the American Association for the Study of Liver diseases, November 11-15. 67th Annual Meeting of the American Association for the Study of Liver diseases, November 11-15.; 2016.
Top